Derivatives of...

Details Derivatives of... Derivatives of...

2011-01-11

2011-01-11

Shameem, Golam M (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S268100, C546S268400, C546S272700, C546S273400, C514S336000, C514S337000

Reexamination Certificate

active

07868024

ABSTRACT:
The invention relates to compounds of formula (I):Wherein X1, X2, X3, X4, Y and W are as described herein. The invention also relates to a preparation method and to a therapeutic application.

REFERENCES:
patent: 7384969 (2008-06-01), Dubois et al.
patent: 7407950 (2008-08-01), Dubois et al.
patent: 7557134 (2009-07-01), Dubois et al.
patent: 7745467 (2010-06-01), Dubois et al.
patent: 2005/0165049 (2005-07-01), Hulme et al.
patent: 2874015 (2006-02-01), None
patent: WO 02/059110 (2002-08-01), None
patent: WO 03/049702 (2003-06-01), None
patent: WO 03/068749 (2003-08-01), None
patent: WO 2004/072069 (2004-08-01), None
patent: WO 2006/072736 (2006-07-01), None
patent: WO 2007010144 (2007-01-01), None
Antilla, J. C., et al. , Copper-Diamine-Catalyzed N-Arylation of Pyrroles, Pyrazoles, Indazoles, Imidazoles, and Triazoles, J. Org. Chem., (2004), vol. 69, pp. 5578-5587.
Williams, T. M., et. al, 5-Chloro-3-(Phenylsulfonyl)Indole-2-Carboxamide: A Novel, Non-Nucleoside Inhibitor of HIV-1 Reverse Transcriptase, J. Med. Chem., (1993), vol. 36: pp. 1291-1294.

Affiliated with

Also associated with

Rating

Derivatives of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Derivatives of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2735310